Scientific and Clinical Validation
- Dual CB1/CB2 receptor potent full agonist
- Phase 1 study in subjects with lower back pain that were otherwise healthy demonstrated statistically significant increase in body weight versus drug exposure
- Phase 1b/2a study in process (CAReS Trial)
- Phase 2a complete clinical data from CAReS Trial anticipated in 2H 2022
Learn more about cancer anorexia and the unmet need